These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32196993)

  • 21. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
    Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
    Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
    O'Neal WT; Mazur M; Bertoni AG; Bluemke DA; Al-Mallah MH; Lima JAC; Kitzman D; Soliman EZ
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28546456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure.
    Fröhlich GM; Keller P; Schmid F; Wolfrum M; Osranek M; Falk C; Noll G; Enseleit F; Reinthaler M; Meier P; Lüscher TF; Ruschitzka F; Tanner FC
    Eur Heart J; 2013 May; 34(19):1414-23. PubMed ID: 23355650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
    Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
    J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction].
    Bazaeva EV; Myasnikov RP; Metelskaya VA; Boytsov SA
    Kardiologiia; 2017 Mar; 57(3):39-45. PubMed ID: 28762934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.
    Markousis-Mavrogenis G; Tromp J; Ouwerkerk W; Devalaraja M; Anker SD; Cleland JG; Dickstein K; Filippatos GS; van der Harst P; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; Zannad F; Zwinderman AH; Hillege HL; van Veldhuisen DJ; Kakkar R; Voors AA; van der Meer P
    Eur J Heart Fail; 2019 Aug; 21(8):965-973. PubMed ID: 31087601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
    Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
    J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction.
    Lourenço P; Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Leite-Moreira A; Bettencourt P
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):23-29. PubMed ID: 30407267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis.
    Yeboah J; Rodriguez CJ; Qureshi W; Liu S; Carr JJ; Lima JA; Hundley WG; Herrington DM
    J Card Fail; 2016 Oct; 22(10):763-8. PubMed ID: 27038640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated Echocardiograms Do Not Provide Incremental Prognostic Value to Single Echocardiographic Assessment in Minimally Symptomatic Patients with Chronic Heart Failure: Results of the Bio-SHiFT Study.
    van den Berg VJ; Strachinaru M; Akkerhuis KM; Baart S; Brankovic M; Constantinescu AA; Cornel JH; Manintveld OC; Umans VAWM; Rizopoulos D; Geleijnse ML; Boersma E; van Dalen BM; Kardys I
    J Am Soc Echocardiogr; 2019 Aug; 32(8):1000-1009. PubMed ID: 31230778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: A 36-month follow-up cohort study.
    Wang H; Li N; Shao X; Li J; Guo L; Yu X; Sun Y; Hao J; Niu H; Xiang J; Li X; Han X
    Clin Chim Acta; 2019 Aug; 495():338-344. PubMed ID: 31059702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function.
    Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
    Diab Vasc Dis Res; 2018 Nov; 15(6):494-503. PubMed ID: 30176743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating endostatin and the incidence of heart failure.
    Ruge T; Carlsson AC; Ingelsson E; Risérus U; Sundström J; Larsson A; Lind L; Ärnlöv J
    Scand Cardiovasc J; 2018 Oct; 52(5):244-249. PubMed ID: 29893146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.